Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fibbe, W E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fibbe, W E
Annals of the Rheumatic Diseases 2002;61:ii29-ii31
© 2002 by Annals of the Rheumatic Diseases


REPORT

Mesenchymal stem cells. A potential source for skeletal repair

W E Fibbe

Laboratory of Experimental Haematology, Department of Haematology, Leiden University Medical Centre, Leiden, Netherlands

Correspondence to:
Correspondence to:
Dr W E Fibbe, Department of Haematology, Leiden University Medical Centre, Location C2R – Room 137, 2333 AA Leiden, Netherlands;
W.E.Fibbe@LUMC.nl

Keywords: mesenchymal stem cells; skeletal repair

Abbreviations: MSC, mesenchymal stem cell; CFU-F, colony forming unit fibroblastic

The first 150 words of the full text of this article appear below.

The bone marrow serves as a reservoir for different classes of stem cells. In addtion to haematopoietic stem cells the bone marrow comprises a population of marrow stromal cells or mesenchymal stem cells (MSCs). Stromal cells exhibit multilineage differentiation capacity, and are able to generate progenitors with restricted developmental potential, including fibroblasts, osteoblasts, adipocytes, and chondrocyte progenitors.1–3

Recently, techniques have become available to isolate and grow mesenchymal progenitors and to manipulate their growth under defined in vitro culture conditions. As a result MSCs can be rapidly expanded to numbers that are required for clinical application. Here the role of MSCs for repair of bone and cartilage is discussed.


MARROW STROMAL CELLS
Marrow stromal cells comprise a heterogenous population of cells, including reticular endothelial cells, fibroblasts, adipocytes, and osteogenic precursor cells that provide growth factors, cell to cell interactions, and matrix proteins that play a part in the regulation of haematopoiesis.4–6 The notion that . . . [Full text of this article]




This article has been cited by other articles:


Home page
DiabetesHome page
R. Abdi, P. Fiorina, C. N. Adra, M. Atkinson, and M. H. Sayegh
Immunomodulation by Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Type 1 Diabetes
Diabetes, July 1, 2008; 57(7): 1759 - 1767.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
B. Dekel, E. Shezen, S. Even-Tov-Friedman, H. Katchman, R. Margalit, A. Nagler, and Y. Reisner
Transplantation of Human Hematopoietic Stem Cells into Ischemic and Growing Kidneys Suggests a Role in Vasculogenesis but Not Tubulogenesis
Stem Cells, May 1, 2006; 24(5): 1185 - 1193.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
W. Kafienah, S. Mistry, C. Williams, and A. P. Hollander
Nucleostemin Is a Marker of Proliferating Stromal Stem Cells in Adult Human Bone Marrow
Stem Cells, April 1, 2006; 24(4): 1113 - 1120.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Liu, D. M. Kemeny, B. C. Heng, H. W. Ouyang, A. J. Melendez, and T. Cao
The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells.
J. Immunol., March 1, 2006; 176(5): 2864 - 2871.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. Yokota, Y. Kawakami, Y. Nagai, J.-x. Ma, J.-Y. Tsai, P. W. Kincade, and S. Sato
Bone Marrow Lacks a Transplantable Progenitor for Smooth Muscle Type {alpha}-Actin-Expressing Cells
Stem Cells, January 1, 2006; 24(1): 13 - 22.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & European League Against Rheumatism